[FOR RELEASE March 12, 2014 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2013 -- FY13 Total Sales Up 10.0% to $203.4 Million -- -- FY13 Operating Margin Up 240 Basis Points to 42.7% -- -- FY13 Non-GAAP Net Income Up 22.9% to $59.0 Million -- -- Issues FY14 Forecast -- BEIJING, China – March 12,] []
[] [Consent of Independent Registered Public Accounting Firm The Board of Directors China Biologic Products, Inc.: We consent to the incorporation by reference in registration statements (No. 333-171069 and 333-182624) on Form S-3 and the registration statement (No. 333-151263) on Form S-8 of China Biologic Products, Inc. of our reports dated March 12, 2014, with respect to the consolidated balance sheets] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th 12 David (Xiaoying) Gao Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th 12 Ming Yang Chief Financial Officer (Principal Financial and Accounting Officer)]
[16938C106 CUSIP No. 1. Names of Reporting Persons. WP X Biologics LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions). x ¨ (a) 3. SEC Use Only 4. Source of Funds (See Instructions) WC 5.]
[16938C106 CUSIP No. 1. Names of Reporting Persons. WP X Biologics LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions). x ¨ (a) 3. SEC Use Only 4. Source of Funds (See Instructions) WC 5.]
[Siu Ling Chan 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ ¨ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS PF 5 ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION People’s Republic of China NUMBER OF 7 SOLE VOTING POWER 1 3,012,624 SHARES BENEFICIALLY]
[Siu Ling Chan 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ ¨ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS PF 5 ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION People’s Republic of China NUMBER OF 7 SOLE VOTING POWER 1 3,012,624 SHARES BENEFICIALLY]
[CREDIT AGREEMENT Dated as of February 25, 2014 between CHINA BIOLOGIC PRODUCTS, INC. as Borrower, and CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH as Lender TABLE OF CONTENTS Page No. SECTION 1 Definitions 1 1.1 Definitions 1 1.2 Other Definitional Provisions 8 1.3 Computation of Time Periods 8 1.4 Accounting Terms 8 SECTION 2 THE CREDIT FACILITIES 9 2.1] [STANDBY LETTER OF CREDIT DATE OF ISSUE: February 26 , 2014 ADVISING BANK: CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH STANDBY LETTER OF CREDIT REF.: 110LG1400023 DATE OF EXPIRY: February 25, 2016 BENEFICIARY (NAME AND ADDRESS): CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH, NY DEAR SIRS, AT THE REQUEST OF SHANDONG TAIBANG BIOLOGICAL PRODUCTS CO., LTD. (APPLICANT), WE] [STANDBY LETTER OF CREDIT DATE OF ISSUE: February 26, 2014 ADVISING BANK: CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH STANDBY LETTER OF CREDIT REF.: 110LG1400024 DATE OF EXPIRY: August 25 , 2015 BENEFICIARY (NAME AND ADDRESS): CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH, NY DEAR SIRS, AT THE REQUEST OF SHANDONG TAIBANG BIOLOGICAL PRODUCTS CO., LTD. (APPLICANT), WE] [Guarantee Agreement (Applicable to Any Guarantee Provided by Bank) No: 110LG1400023 Agreement This Guarantee Agreement (hereinafter referred to as this “ Principal 1. Shandong Taibang Biological Products Co., Ltd., as the principal (hereinafter referred to as the “ Guarantor 2. China Merchants Bank Co., Ltd., Beijing Shuangyushu Branch, as the guarantor (hereinafter referred to as the “ ¨ Credit Agreement] [Guarantee Agreement (Applicable to Any Guarantee Provided by Bank) No: 110LG1400024 Agreement This Guarantee Agreement (hereinafter referred to as this “ Principal 1. Shandong Taibang Biological Products Co., Ltd., as the principal (hereinafter referred to as the “ Guarantor 2. China Merchants Bank Co., Ltd., Beijing Shuangyushu Branch, as the guarantor (hereinafter referred to as the “ ¨ Credit Agreement] [FOR RELEASE March 3, 2014 China Biologic Completes Stock Repurchase Transaction BEIJING, China – March 3, 2014 – Mr. David (Xiaoying) Gao, Chairman and Chief Executive Officer of China Biologic, commented, “In the past six months, we have closed two share repurchase transactions totaling 3.98 million shares of common stock for a total consideration of $99.6 million. Through these repurchase] []
[CREDIT AGREEMENT Dated as of February 25, 2014 between CHINA BIOLOGIC PRODUCTS, INC. as Borrower, and CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH as Lender TABLE OF CONTENTS Page No. SECTION 1 Definitions 1 1.1 Definitions 1 1.2 Other Definitional Provisions 8 1.3 Computation of Time Periods 8 1.4 Accounting Terms 8 SECTION 2 THE CREDIT FACILITIES 9 2.1] [STANDBY LETTER OF CREDIT DATE OF ISSUE: February 26 , 2014 ADVISING BANK: CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH STANDBY LETTER OF CREDIT REF.: 110LG1400023 DATE OF EXPIRY: February 25, 2016 BENEFICIARY (NAME AND ADDRESS): CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH, NY DEAR SIRS, AT THE REQUEST OF SHANDONG TAIBANG BIOLOGICAL PRODUCTS CO., LTD. (APPLICANT), WE] [STANDBY LETTER OF CREDIT DATE OF ISSUE: February 26, 2014 ADVISING BANK: CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH STANDBY LETTER OF CREDIT REF.: 110LG1400024 DATE OF EXPIRY: August 25 , 2015 BENEFICIARY (NAME AND ADDRESS): CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH, NY DEAR SIRS, AT THE REQUEST OF SHANDONG TAIBANG BIOLOGICAL PRODUCTS CO., LTD. (APPLICANT), WE] [Guarantee Agreement (Applicable to Any Guarantee Provided by Bank) No: 110LG1400023 Agreement This Guarantee Agreement (hereinafter referred to as this “ Principal 1. Shandong Taibang Biological Products Co., Ltd., as the principal (hereinafter referred to as the “ Guarantor 2. China Merchants Bank Co., Ltd., Beijing Shuangyushu Branch, as the guarantor (hereinafter referred to as the “ ¨ Credit Agreement] [Guarantee Agreement (Applicable to Any Guarantee Provided by Bank) No: 110LG1400024 Agreement This Guarantee Agreement (hereinafter referred to as this “ Principal 1. Shandong Taibang Biological Products Co., Ltd., as the principal (hereinafter referred to as the “ Guarantor 2. China Merchants Bank Co., Ltd., Beijing Shuangyushu Branch, as the guarantor (hereinafter referred to as the “ ¨ Credit Agreement] [FOR RELEASE March 3, 2014 China Biologic Completes Stock Repurchase Transaction BEIJING, China – March 3, 2014 – Mr. David (Xiaoying) Gao, Chairman and Chief Executive Officer of China Biologic, commented, “In the past six months, we have closed two share repurchase transactions totaling 3.98 million shares of common stock for a total consideration of $99.6 million. Through these repurchase] []
[GL Trade Investment Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 1,605,315 6]
[GL Trade Investment Limited 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 1,605,315 6]
